Statistics for Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor
Total visits
views | |
---|---|
Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor | 248 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
java.util.UUID:14f028aa-6896-4132-acd5-a6057c3305ba | 5 |
Top country views
views | |
---|---|
United States | 189 |
Germany | 15 |
Ukraine | 6 |
United Kingdom | 5 |
Sweden | 5 |
Canada | 4 |
Russia | 4 |
China | 2 |
Japan | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 54 |
Fairfield | 30 |
Ann Arbor | 24 |
Kiez | 14 |
Cambridge | 9 |
Houston | 8 |
Jacksonville | 7 |
White Plains | 7 |
Kiev | 6 |
Indianapolis | 4 |
Dearborn | 3 |
Saint Petersburg | 3 |
San Francisco | 3 |
Stockholm | 3 |
Toronto | 3 |
Lake Mary | 2 |
Mcallen | 2 |
Washington | 2 |
Abingdon | 1 |
Baltimore | 1 |
Beijing | 1 |
Brooklyn | 1 |
Guangzhou | 1 |
Gunzenhausen | 1 |
Kalmar | 1 |
Lachine | 1 |
London | 1 |
Manchester | 1 |
Marcus Hook | 1 |
Moscow | 1 |
New York | 1 |
Norrtälje | 1 |
Philadelphia | 1 |
Seattle | 1 |
Seremban | 1 |
Woburn | 1 |